C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2004
10/20/2004	EP1468119A2 A METHOD OF DEVELOPING AN ANTI−PROTEIN AND REGULATION OF A CELLULAR FUNCTION BY ADMINISTERING AN EFFECTIVE AMOUNT OF THE ANTI−PROTEIN
10/20/2004	EP1468100A2 Gb virus b based replicons and replicon enhanced cells
10/20/2004	EP1468097A2 METHODS OF GENERATING MULTISPECIFIC, MULTIVALENT AGENTS FROM V sb H /sb AND V sb L /sb DOMAINS
10/20/2004	EP1468096A2 Selective plant growth using d-amino acids
10/20/2004	EP1468094A1 Method of transducing es cells
10/20/2004	EP1468092A2 Pim-3 kinase as a target for type 2 diabetes mellitus
10/20/2004	EP1468091A2 Transmembrane protein
10/20/2004	EP1468088A2 Stem cell maturation for all tissue types
10/20/2004	EP1468079A1 Dhfr-deficient cho cell line transfected with an anti-apoptotic gene, method for preparation thereof, and method for producing target protein using the same
10/20/2004	EP1468078A1 Method and device for identifying substances capable of modulating adipocyte differentiation
10/20/2004	EP1468020A2 Multimers of receptor-binding ligands
10/20/2004	EP1468019A2 Secreted protein
10/20/2004	EP1468018A2 Leptin proteins
10/20/2004	EP1468017A1 A complex of a human foxc2 protein and a foxc2-interacting protein
10/20/2004	EP1468014A2 Compositions and methods for wt1 specific immunotherapy
10/20/2004	EP1468011A1 Biomolecule transduction motif sim-2-btm and the use thereof
10/20/2004	EP1467768A1 Increasing electro-gene transfer of nucleic acid molecules into host tissue
10/20/2004	EP1467759A2 Compositions and methods related to tim-3, a th1-specific cell surface molecule
10/20/2004	EP1467752A1 HUMAN MAST CELL−EXPRESSED MEMBRANE PROTEINS
10/20/2004	EP1467748A1 Stimulation of bone growth and cartilage formation with thrombing peptide derivatives
10/20/2004	EP1467624A2 Methods of inducing or enhancing connective tissue repair
10/20/2004	EP1467615A1 Methods to engineer mammalian-type carbohydrate structures
10/20/2004	EP1404180A4 Peripheral blood fibrocytes differentiation pathway and migration to wound sites
10/20/2004	EP1194450B1 Inactivated vaccine against feline calicivirus disease
10/20/2004	EP1179179B1 Use of an antibody to detect basophiles and/or mast cells
10/20/2004	EP0956355B1 Method for immortalizing cells
10/20/2004	EP0886644B1 Long wavelength engineered fluorescent proteins
10/20/2004	EP0880590B1 Esterases
10/20/2004	EP0831860B1 Allogeneic cell therapy for cancer following allogeneic stem cell transplantation
10/20/2004	EP0739416A4 Enzyme based bioremediation
10/20/2004	EP0658113B1 Isolated nonapeptide derived from mage-3 gene and presented by hla-a1, and uses thereof
10/20/2004	CN1539016A sd1 gene participating in plant semidwarfing and ultilization thereof
10/20/2004	CN1538854A Mutant forms of cholera holotoxin as adjuvant
10/20/2004	CN1538853A T cell regulatory genes and methods of use thereof
10/20/2004	CN1537952A New alginate monoclone antiboeg and its preparation method and use
10/20/2004	CN1537940A Method fornursing and culturing plant protoplast
10/20/2004	CN1537937A Application of recombination human ciliary nerve nutrition foctor in proparing adult multi function muscle stem cell
10/20/2004	CN1537936A Use of recobimation human ciliary nerve nutrition factor in inhibiting adult sarcoblast natural differentiation
10/20/2004	CN1171997C Modified TLE-2-receptor ligands
10/20/2004	CN1171996C American pig reproduction and respiratory syndrome syndrome (PRRS) virus and its use
10/20/2004	CN1171993C Novel genes coding amino acid deacetylases with specificity for N-acetyl-L-phosphinothricin, their isolation and their use
10/20/2004	CN1171991C Culture process for human nerve stem cell
10/20/2004	CN1171902C Antisercretory factor petides regulating pathological permeability changes
10/20/2004	CN1171900C Novel, ubiquitous potassium-channel proteins and genes for the same
10/19/2004	US6806351 Nucleotide sequences coding proteins for use in the diagnosis and treatment of hematopoietic or immune disorders
10/19/2004	US6806064 A viral nucleic acid construct for the high level expression of a heterologous protein in an insect cell; using baculovirus expression vector system for exogenous proteins production
10/19/2004	US6806063 Protein conjugate for use in the treatment of blood disorder
10/19/2004	US6806061 G protein-coupled receptor gene and methods of use therefor
10/19/2004	US6806059 Nucleotide sequences coding enzymatic polypeptide for use innthe treatment of asthma, and for use in laundry detergent and stain removers
10/19/2004	US6805864 Type I angiotensin II receptor specific monoclonal antibodies and hybridomas
10/19/2004	US6805861 Administering therapeutically effective amount of cytotoxic t lymphocytes which have different hla class i complex (or equivalent) than cells to be killed, and specifically recognize peptide portion of antigen presented on cell surface
10/19/2004	US6805860 Delivering stem cells to site of tissue repair in region damaged by myocardial disease through blood vessel leading to site by advancing catheter through vessel, occluding vessel during delivery to increase concentration of delivered cells
10/19/2004	CA1341459C Modified fibrinolytic enzymes
10/14/2004	WO2004088321A1 Method for the enrichment of target cells by use of cbds
10/14/2004	WO2004088283A2 Apparatus and methods for providing sex-sorted animal sperm
10/14/2004	WO2004087926A1 A promoter construct for gene expression in neuronal cells
10/14/2004	WO2004087911A1 Method of constructing hybridoma producing antigen-specific antibody using single antigen-specific b lymphocyte and method of producing monoclonal antibody
10/14/2004	WO2004087899A1 Method for obtaining regulating dendritic cells and t cells
10/14/2004	WO2004087898A1 Method of transplanting foreign cell into mammalian embryo
10/14/2004	WO2004087897A1 Method of producing lens cell and lens cell obtained by the method
10/14/2004	WO2004087896A2 Hepatocyte differentiation of stem cells
10/14/2004	WO2004087885A2 Method for transdifferentiation of non-pancreatic stem cells to the pancreatic pathway
10/14/2004	WO2004087870A2 Neuronal cell lineages and methods of production thereof
10/14/2004	WO2004087860A2 Materials and methods for regulating process formation in cell culture
10/14/2004	WO2004087760A1 Antibodies directed against hepatitis c virus e1e2 complex, compositions of hcv particles, and pharmaceutical compositions
10/14/2004	WO2004087756A2 Antibodies against insulin-like growth factor i receptor and uses thereof
10/14/2004	WO2004087736A2 Uses of vascular endothelial growth factor and type i collagen inducible protein (vcip)
10/14/2004	WO2004087177A1 Process for the staining of sperm
10/14/2004	WO2004087055A2 Use of fgf- 18 protein, target proteins and their respective encoding nucleotide sequences to induce cartilage formation
10/14/2004	WO2004087044A2 Drug target
10/14/2004	WO2004072253A9 Human excitatory amino acid transporter-2 gene promoter and uses thereof
10/14/2004	WO2004048527A8 Cells resistant to chemotherapeutic compounds and uses thereof
10/14/2004	WO2004039248A3 Repairing or replacing tissues or organs
10/14/2004	WO2004034890A3 Biological scaffolding material
10/14/2004	WO2004029230A3 Cells on a support matrix for tissue repair
10/14/2004	WO2004024875A8 Mammalian megakaryocyte progenitor cell
10/14/2004	WO2004024063A3 Compositions and methods for the diagnosis and treatment of tumor
10/14/2004	WO2004021010A3 Method of diagnosing colon and gastric cancers
10/14/2004	WO2004016740A3 Humanized rabbit antibodies
10/14/2004	WO2004015067A3 Sperm-specific cation channel, catsper-3, and uses therefor
10/14/2004	WO2004009780A3 Preventing ischemia-induced cell damage
10/14/2004	WO2003100018A3 A bank of stem cells for transplantation
10/14/2004	WO2003099233A3 Microbial conversion of glucose to para-hydroxystyrene
10/14/2004	WO2003089620A3 Phospholipases, nucleic acids encoding them and methods for making and using them
10/14/2004	WO2003075945A3 Cg8327, cg10823, cg18418, cg15862, cg3768, cg11447 and cg16750 homologous proteins involved in the regulation of energy homeostasis
10/14/2004	WO2003072700A3 Androgen receptor overexpressing skeletal myoblasts
10/14/2004	WO2003065985A3 Uses of mammalian cytokine; related reagents
10/14/2004	WO2003061595A3 Antibodies against and compositions containing new amphetamine derivatives
10/14/2004	WO2003052057A3 Egvi endoglucanase and nucleic acids encoding the same
10/14/2004	WO2003031475A8 Antibodies against kdr, their production and uses
10/14/2004	WO2001075067A8 Novel nucleic acids and polypeptides
10/14/2004	US20040205845 Chimeric potato comprising vector expressing sequences which reduce or inhibit adenylate kinase activities thereby enhancing starch accumulation; tissue engineering
10/14/2004	US20040205835 Jak kinases and regulation of cytokine signal transduction
10/14/2004	US20040205834 System for inducible expression in eukaryotic cells
10/14/2004	US20040204579 Comprises starch synthase for use in enhancing digestibility of food stuffs, paper processing, adhesives and textile processing
10/14/2004	US20040204574 TSA305 gene
10/14/2004	US20040204563 Generating transgenic bacteria coding/expressing eschrichia thioredoxin fusion protein for use as diagnostic marker in heterologous gene expression; bioreactors
10/14/2004	US20040204361 Kdel receptor inhibitors
10/14/2004	US20040204350 Disease- associated protein
10/14/2004	US20040204345 Using recombinant zinc finger proteins; use in human therapeutic applications such as cancer therapy and altering plant phenotypes, including disease resistance, fruit ripening

1 ... 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 ... 1827